Municipal Employees' Retirement System of Michigan

The Municipal Employees' Retirement System of Michigan (MERS) is a public pension fund based in Lansing, Michigan, established in 1945 to provide retirement benefits to municipal employees. Serving nearly 100,000 members, including local firefighters, nurses, and public service workers, MERS offers a range of retirement plans, including defined benefit and contribution programs, as well as hybrid options. The system supports various governmental entities such as counties, cities, townships, and hospitals, ensuring affordable and sustainable retirement solutions for its participants. MERS is focused on managing its substantial assets effectively, with an executive management team overseeing investment strategies that include alternative investments across multiple sectors. The organization is committed to enhancing the financial security of its members, fostering strong retirement outcomes through prudent asset management.

Michael Charette

Managing Director of Investments

Brom Stibitz

COO

6 past transactions

Calysta

Series D in 2021
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.

Calysta

Series E in 2019
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.

Trice Medical

Series C in 2019
Trice Medical, Inc. is a company that specializes in the development of innovative orthopedic diagnostic devices featuring integrated camera-enabled and needle-based technologies. Founded in 2011 and headquartered in Malvern, Pennsylvania, Trice Medical aims to enhance patient care by providing immediate and accurate diagnostic solutions that can be administered in a physician's office. Their products facilitate minimally invasive procedures that are designed to be painless, cosmetically undetectable, and of surgical grade quality. By optimizing the diagnostic process, Trice Medical seeks to eliminate inaccuracies associated with traditional indirect modalities, thereby reducing costs for the healthcare system while improving the overall patient experience.

Calysta

Series D in 2017
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.

Aperia Technologies

Series B in 2016
Aperia Technologies, Inc. is a company that specializes in automatic tire inflation devices aimed at enhancing the safety and efficiency of commercial vehicles. Its flagship product, the Halo Tire Inflator, is a self-powered, bolt-on device that utilizes the rotational motion of a wheel to maintain optimal tire pressure by compensating for minor leaks and pressure changes due to temperature fluctuations. This technology is particularly beneficial for a variety of fleet vehicles, including buses, box trucks, tractors, trailers, and refuse vehicles. By ensuring proper tire inflation, Aperia Technologies helps fleet operators reduce fuel costs, decrease environmental pollution, and improve overall road safety. Founded in 2010, the company is headquartered in Burlingame, California, and distributes its products through a network of dealers across the United States.

Calysta

Series C in 2016
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.